NAMS smart money
Newamsterdam Pharma Co N.V. (NAMS): 1 insider buy, 10 top funds holding it, 1 ETF change in the public filings.
Insider buys, 12 months$226k
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-09-15 | Davidson Michael H. | Chief Executive Officer | $226k | $22.65 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 29 | Slate Path Capital LP | 0.12% | $8M | |
| 31 | Affinity Asset Advisors, LLC | 0.39% | $7M | |
| 31 | Affinity Asset Advisors, LLC | 0.18% | $3M | |
| 48 | Nwi Management LP | 0.96% | $17M | |
| 58 | Bain Capital Life Sciences Investors, LLC | 6.21% | $93M | |
| 58 | Bain Capital Life Sciences Investors, LLC | 0.08% | $1M | |
| 67 | Duquesne Family Office LLC | ADD +9% | 1.97% | $82M |
| 74 | First Turn Management, LLC | ADD +21% | 2.27% | $17M |
| 76 | Polar Capital Holdings PLC | TRIM -50% | 0.06% | $21M |
| 86 | Adar1 Capital Management, LLC | 0.13% | $3M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| Capital Group U.S. Small And Mid Cap ETF | ADD | +$19M | 2026-05-31 |